FINANCIAL INFORMATION BY BUSINESS AREA
Quarterly data
Net sales by business area
| 2025 | 2024 | ||||||||
| SEKm | Q2 | Q1 | Q4 | Q3 | Q2 | Q1 | |||
| Labtech | 985 | 989 | 1,141 | 852 | 941 | 863 | |||
| Medtech | 1,594 | 1,714 | 1,679 | 1,494 | 1,615 | 1,708 | |||
| Group items | -1 | -1 | -2 | -2 | -2 | -1 | |||
| The Group | 2,578 | 2,702 | 2,818 | 2,344 | 2,554 | 2,570 | |||
EBITA by business area
| 2025 | 2024 | ||||||||
| SEKm | Q2 | Q1 | Q4 | Q3 | Q2 | Q1 | |||
| Labtech | 122 | 120 | 161 | 76 | 109 | 99 | |||
| Medtech | 198 | 231 | 195 | 153 | 200 | 198 | |||
| Group items | -13 | -8 | -10 | -6 | -10 | -6 | |||
| EBITA | 307 | 343 | 346 | 223 | 299 | 291 | |||
Adjusted EBITA / Adjusted EBITA margin by business area
| 2025 | 2024 | ||||||||
| SEKm | Q2 | Q1 | Q4 | Q3 | Q2 | Q1 | |||
| Labtech | 122 | 120 | 161 | 76 | 109 | 99 | |||
| Medtech | 198 | 231 | 195 | 160 | 193 | 204 | |||
| Parent Company and Group items | -13 | -8 | -10 | -6 | -10 | -6 | |||
| Adjusted EBITA | 307 | 343 | 346 | 230 | 292 | 297 | |||
| 2025 | 2024 | ||||||||
| % | Q2 | Q1 | Q4 | Q3 | Q2 | Q1 | |||
| Labtech | 12.4 | 12.1 | 14.1 | 8.9 | 11.6 | 11.5 | |||
| Medtech | 12.4 | 13.5 | 11.6 | 10.7 | 11.9 | 11.9 | |||
| The Group’s adjusted EBITA margin | 11.9 | 12.7 | 12.3 | 9.8 | 11.4 | 11.6 | |||
Latest updated: 7/13/2025 9:50:16 PM by Johanna Prim